Physician profile
Michael J Grady
NPI 1376574111
$1,563.54
in general payments reported to CMS, 2019-2025
26 companies · $370 in 2025
The $370 reported for 2025 was more than what 89% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $111 · 2020: $32.40 · 2021: $70.93 · 2022: $178 · 2023: $313 · 2024: $488 · 2025: $370.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,171.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,170.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $483.40 | 2022-2025 | Bexsero |
| Cranial Technologies, INC | $191.24 | 2022-2025 | Doc Band |
| Supernus Pharmaceuticals, INC. | $156.49 | 2023-2025 | Qelbree, Qelbree |
| Merck Sharp & Dohme LLC | $77.83 | 2023-2025 | Vaxneuvance, Enflonsia, Gardasil 9 |
| Pfizer INC. | $66.75 | 2022-2025 | |
| Ironshore Pharmaceuticals INC. | $60.01 | 2019-2024 | |
| Tris Pharma INC | $47.40 | 2020-2022 | |
| Shire North American Group INC | $41.14 | 2019 | |
| Welch Allyn | $38.97 | 2021 | |
| Baxter Healthcare | $38.97 | 2022 | |
| Acadia Pharmaceuticals INC | $34.44 | 2023 | Daybue |
| Collegium Pharmaceutical, INC. | $34.19 | 2025 | Jornay Pm |
| Lnhc, INC | $32.35 | 2025 | Zelsuvmi |
| Genentech USA, INC. | $25.87 | 2019 | |
| Corium, LLC | $24.99 | 2025 | Azstarys |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cipher Pharmaceuticals US LLC | $23.72 | 2025 | Natroba, Spinosad |
| Ultragenyx Pharmaceutical INC. | $23.48 | 2022 | |
| Sobi, INC | $22.79 | 2022 | |
| Sanofi Pasteur INC. | $21.79 | 2022 | |
| Verrica Pharmaceuticals INC. | $19.11 | 2024 | Ycanth |
| Takeda Pharmaceuticals U.S.A., INC. | $17.58 | 2021 | |
| Hollister Incorporated | $17.14 | 2024 | |
| Abc Home Medical Supply, INC. | $17.14 | 2024 | |
| Neos Therapeutics, LP | $16.92 | 2020 | |
| Kowa Pharmaceuticals America, INC. | $15.96 | 2025 | Zoryve |
| Photonicare INC | $13.87 | 2024 | Otosight Middle Ear Scope |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Grady listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.